Literature DB >> 15042430

Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis.

Genshu Tate1, Takao Suzuki2, Koji Kishimoto2, Toshiyuki Mitsuya2.   

Abstract

Germline mutations of the EVER1/TMC6 gene are associated with epidermodysplasia verruciformis (EV), which is characterized by an abnormal susceptibility to human papillomaviruses that were considered to be innocuous for the general population. In this study, we have employed polymerase chain reaction and DNA sequencing analysis to characterize the EVER1 gene in a 65-year-old Japanese EV patient. Direct sequence analyses resulted in the identification of two novel mutations. One nonsense mutation consisting of a (C>A) transversion at nucleotide 744 in exon 8 in one EVER1 allele resulted in the introduction of a premature termination codon (Y248X). Another mutation was identified in the splice acceptor site of intron 8 (892-2, IVS8-2, A>T) in another allele. This is the second report of EVER1/TMC6 mutations in EV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042430     DOI: 10.1007/s10038-004-0135-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  4 in total

1.  Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.

Authors:  Nicolas Ramoz; Luis-Alfredo Rueda; Bakar Bouadjar; Luz-Stella Montoya; Gérard Orth; Michel Favre
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

2.  A new germline mutation of the PTCH gene in a Japanese patient with nevoid basal cell carcinoma syndrome associated with meningioma.

Authors:  Genshu Tate; Min Li; Takao Suzuki; Toshiyuki Mitsuya
Journal:  Jpn J Clin Oncol       Date:  2003-01       Impact factor: 3.019

3.  Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis.

Authors:  Kiyoto Kurima; Yandan Yang; Katherine Sorber; Andrew J Griffith
Journal:  Genomics       Date:  2003-09       Impact factor: 5.736

4.  TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins.

Authors:  Gabor Keresztes; Hideki Mutai; Stefan Heller
Journal:  BMC Genomics       Date:  2003-06-17       Impact factor: 3.969

  4 in total
  12 in total

Review 1.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

2.  Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.

Authors:  David F McDermott; Bryan Gammon; Peter J Snijders; Ihunanya Mbata; Beth Phifer; A Howland Hartley; Chyi-Chia Richard Lee; Philip M Murphy; Sam T Hwang
Journal:  Pediatr Dermatol       Date:  2009 May-Jun       Impact factor: 1.588

3.  Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study.

Authors:  Anita S Patel; Margaret R Karagas; Michael Pawlita; Tim Waterboer; Heather H Nelson
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

4.  Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.

Authors:  Amandine Crequer; Anja Troeger; Etienne Patin; Cindy S Ma; Capucine Picard; Vincent Pedergnana; Claire Fieschi; Annick Lim; Avinash Abhyankar; Laure Gineau; Ingrid Mueller-Fleckenstein; Monika Schmidt; Alain Taieb; James Krueger; Laurent Abel; Stuart G Tangye; Gérard Orth; David A Williams; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

5.  A distinct variant of Epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations.

Authors:  Baki Akgül; Osman Köse; Mükerrem Safali; Karin Purdie; Rino Cerio; Charlotte Proby; Alan Storey
Journal:  J Dermatol Sci       Date:  2007-02-16       Impact factor: 4.563

6.  Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.

Authors:  Rui Yoshida; Toshihiko Kato; Masahiko Kawase; Mariko Honda; Tsuyoshi Mitsuishi
Journal:  BMC Dermatol       Date:  2014-07-21

Review 7.  The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients.

Authors:  Agnieszka Kalińska-Bienias; Cezary Kowalewski; Sławomir Majewski
Journal:  Postepy Dermatol Alergol       Date:  2016-05-16       Impact factor: 1.837

8.  The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.

Authors:  Sarah Jill de Jong; Amandine Créquer; Irina Matos; David Hum; Vignesh Gunasekharan; Lazaro Lorenzo; Fabienne Jabot-Hanin; Elias Imahorn; Andres A Arias; Hassan Vahidnezhad; Leila Youssefian; Janet G Markle; Etienne Patin; Aurelia D'Amico; Claire Q F Wang; Florian Full; Armin Ensser; Tina M Leisner; Leslie V Parise; Matthieu Bouaziz; Nataly Portilla Maya; Xavier Rueda Cadena; Bayaki Saka; Amir Hossein Saeidian; Nessa Aghazadeh; Sirous Zeinali; Peter Itin; James G Krueger; Lou Laimins; Laurent Abel; Elaine Fuchs; Jouni Uitto; Jose Luis Franco; Bettina Burger; Gérard Orth; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2018-08-01       Impact factor: 17.579

9.  Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.

Authors:  Amandine Crequer; Capucine Picard; Etienne Patin; Aurelia D'Amico; Avinash Abhyankar; Martine Munzer; Marianne Debré; Shen-Ying Zhang; Geneviève de Saint-Basile; Alain Fischer; Laurent Abel; Gérard Orth; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

10.  The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.

Authors:  Jaime S Horton; Alexander J Stokes
Journal:  Oncoimmunology       Date:  2014-04-15       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.